260 related articles for article (PubMed ID: 27122588)
1. Furin Cleavage of L2 during Papillomavirus Infection: Minimal Dependence on Cyclophilins.
Bronnimann MP; Calton CM; Chiquette SF; Li S; Lu M; Chapman JA; Bratton KN; Schlegel AM; Campos SK
J Virol; 2016 Jul; 90(14):6224-6234. PubMed ID: 27122588
[TBL] [Abstract][Full Text] [Related]
2. Alpha-defensin HD5 inhibits furin cleavage of human papillomavirus 16 L2 to block infection.
Wiens ME; Smith JG
J Virol; 2015 Mar; 89(5):2866-74. PubMed ID: 25540379
[TBL] [Abstract][Full Text] [Related]
3. Target cell cyclophilins facilitate human papillomavirus type 16 infection.
Bienkowska-Haba M; Patel HD; Sapp M
PLoS Pathog; 2009 Jul; 5(7):e1000524. PubMed ID: 19629175
[TBL] [Abstract][Full Text] [Related]
4. Cleavage of the HPV16 Minor Capsid Protein L2 during Virion Morphogenesis Ablates the Requirement for Cellular Furin during De Novo Infection.
Cruz L; Biryukov J; Conway MJ; Meyers C
Viruses; 2015 Nov; 7(11):5813-30. PubMed ID: 26569287
[TBL] [Abstract][Full Text] [Related]
5. Two highly conserved cysteine residues in HPV16 L2 form an intramolecular disulfide bond and are critical for infectivity in human keratinocytes.
Campos SK; Ozbun MA
PLoS One; 2009; 4(2):e4463. PubMed ID: 19214230
[TBL] [Abstract][Full Text] [Related]
6. Kallikrein-8 Proteolytically Processes Human Papillomaviruses in the Extracellular Space To Facilitate Entry into Host Cells.
Cerqueira C; Samperio Ventayol P; Vogeley C; Schelhaas M
J Virol; 2015 Jul; 89(14):7038-52. PubMed ID: 25926655
[TBL] [Abstract][Full Text] [Related]
7. Phosphorylation of Human Papillomavirus Type 16 L2 Contributes to Efficient Virus Infectious Entry.
Broniarczyk J; Massimi P; Pim D; Bergant Marušič M; Myers MP; Garcea RL; Banks L
J Virol; 2019 Jul; 93(13):. PubMed ID: 30996086
[TBL] [Abstract][Full Text] [Related]
8. Efficient Inhibition of Human Papillomavirus Infection by L2 Minor Capsid-Derived Lipopeptide.
Yan H; Foo SS; Chen W; Yoo JS; Shin WJ; Wu C; Jung JU
mBio; 2019 Aug; 10(4):. PubMed ID: 31387913
[TBL] [Abstract][Full Text] [Related]
9. L2, the minor capsid protein of papillomavirus.
Wang JW; Roden RB
Virology; 2013 Oct; 445(1-2):175-86. PubMed ID: 23689062
[TBL] [Abstract][Full Text] [Related]
10. Cyclophilins facilitate dissociation of the human papillomavirus type 16 capsid protein L1 from the L2/DNA complex following virus entry.
Bienkowska-Haba M; Williams C; Kim SM; Garcea RL; Sapp M
J Virol; 2012 Sep; 86(18):9875-87. PubMed ID: 22761365
[TBL] [Abstract][Full Text] [Related]
11. The S100A10 subunit of the annexin A2 heterotetramer facilitates L2-mediated human papillomavirus infection.
Woodham AW; Da Silva DM; Skeate JG; Raff AB; Ambroso MR; Brand HE; Isas JM; Langen R; Kast WM
PLoS One; 2012; 7(8):e43519. PubMed ID: 22927980
[TBL] [Abstract][Full Text] [Related]
12. Topography of the Human Papillomavirus Minor Capsid Protein L2 during Vesicular Trafficking of Infectious Entry.
DiGiuseppe S; Keiffer TR; Bienkowska-Haba M; Luszczek W; Guion LG; Müller M; Sapp M
J Virol; 2015 Oct; 89(20):10442-52. PubMed ID: 26246568
[TBL] [Abstract][Full Text] [Related]
13. A Novel PDZ Domain Interaction Mediates the Binding between Human Papillomavirus 16 L2 and Sorting Nexin 27 and Modulates Virion Trafficking.
Pim D; Broniarczyk J; Bergant M; Playford MP; Banks L
J Virol; 2015 Oct; 89(20):10145-55. PubMed ID: 26202251
[TBL] [Abstract][Full Text] [Related]
14. Human papillomavirus type 16 minor capsid protein l2 N-terminal region containing a common neutralization epitope binds to the cell surface and enters the cytoplasm.
Kawana Y; Kawana K; Yoshikawa H; Taketani Y; Yoshiike K; Kanda T
J Virol; 2001 Mar; 75(5):2331-6. PubMed ID: 11160736
[TBL] [Abstract][Full Text] [Related]
15. Extracellular Conformational Changes in the Capsid of Human Papillomaviruses Contribute to Asynchronous Uptake into Host Cells.
Becker M; Greune L; Schmidt MA; Schelhaas M
J Virol; 2018 Jun; 92(11):. PubMed ID: 29593032
[TBL] [Abstract][Full Text] [Related]
16. Role of L2 cysteines in papillomavirus infection and neutralization.
Gambhira R; Jagu S; Karanam B; Day PM; Roden R
Virol J; 2009 Oct; 6():176. PubMed ID: 19860897
[TBL] [Abstract][Full Text] [Related]
17. The Cytoskeletal Adaptor Obscurin-Like 1 Interacts with the Human Papillomavirus 16 (HPV16) Capsid Protein L2 and Is Required for HPV16 Endocytosis.
Wüstenhagen E; Hampe L; Boukhallouk F; Schneider MA; Spoden GA; Negwer I; Koynov K; Kast WM; Florin L
J Virol; 2016 Dec; 90(23):10629-10641. PubMed ID: 27654294
[TBL] [Abstract][Full Text] [Related]
18. Identification of a role for the trans-Golgi network in human papillomavirus 16 pseudovirus infection.
Day PM; Thompson CD; Schowalter RM; Lowy DR; Schiller JT
J Virol; 2013 Apr; 87(7):3862-70. PubMed ID: 23345514
[TBL] [Abstract][Full Text] [Related]
19. Translocation of the papillomavirus L2/vDNA complex across the limiting membrane requires the onset of mitosis.
Calton CM; Bronnimann MP; Manson AR; Li S; Chapman JA; Suarez-Berumen M; Williamson TR; Molugu SK; Bernal RA; Campos SK
PLoS Pathog; 2017 May; 13(5):e1006200. PubMed ID: 28463988
[TBL] [Abstract][Full Text] [Related]
20. Targeting synthetic Human Papillomavirus (HPV) L2 disulfide-induced N-terminus conformational epitopes for pan-HPV vaccine development.
Khanal S; Ferraris ED; Zahin M; Joh J; Ghim SJ; Jenson AB
Exp Mol Pathol; 2015 Oct; 99(2):330-4. PubMed ID: 26134615
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]